GBGB9509923.0A
GB9509923D0
(en)
|
1995-05-17 |
1995-05-17 |
Novel compounds
|
PCT/GB1995/001323
WO1996004261A1
(en)
|
1994-07-29 |
1995-06-07 |
Benzoxazoles and pryridine derivatives useful in the treatment of the type ii diabetes
|
BR9508468A
BR9508468A
(en)
|
1994-07-29 |
1995-06-07 |
Compound process for the preparation of the same pharmaceutical composition processes for the treatment and / or prophylaxis of hyperglycemia in a human or non-human mammal and for the treatment of hyperlipidemia hypertension cardiovascular disease some eating disorders the treatment and / or prophylaxis of kidney disease prevention revers o stabilization or retardation of microalbuminuria progression in a human or non-human mammal use of the compound and intermediate compound
|
DZ950094A
DZ1916A1
(en)
|
1994-07-29 |
1995-07-26 |
New compounds and pharmaceutical compositions containing them.
|
IL11475995A
IL114759A
(en)
|
1994-07-29 |
1995-07-27 |
Benzoxazole derivatives and pharmaceutical compositions containing them
|
IL12552595A
IL125525A
(en)
|
1994-07-29 |
1995-07-27 |
Hydroxyalkylamine derivatives
|
MA23972A
MA23632A1
(en)
|
1994-07-29 |
1995-07-27 |
PROCESS FOR THE PREPARATION OF NEW COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
|
AU33826/95A
AU697545B2
(en)
|
1994-07-29 |
1995-07-28 |
Benzoxazoles and pyridine derivatives useful in the treatment of the ty pe II diabetes
|
TR95/00916A
TR199500916A2
(en)
|
1994-07-29 |
1995-07-28 |
New compounds to be used in the type.
|
CZ97254A
CZ25497A3
(en)
|
1994-07-29 |
1995-07-28 |
Benzoxazoles and pyridine derivatives usable for treating type ii diabetes
|
CN95195163A
CN1158123A
(en)
|
1994-07-29 |
1995-07-28 |
Benzoxazoles and pyridine derivatives useful in the treatment of the type II diabetes
|
MX9700763A
MX9700763A
(en)
|
1994-07-29 |
1995-07-28 |
Benzoxazoles and pryridine derivatives useful in the treatment of the type ii diabetes.
|
PL95318766A
PL318766A1
(en)
|
1994-07-29 |
1995-07-28 |
Derivatives of benzoxazoles and pyridines useful in treating diabetes of type ii
|
EP95930436A
EP0772605A1
(en)
|
1994-07-29 |
1995-07-28 |
Benzoxazoles and pyridine derivatives useful in the treatment of the type ii diabetes
|
SK122-97A
SK12297A3
(en)
|
1994-07-29 |
1995-07-28 |
Benzoxazoles, pyridine derivatives, process for producing same pharmaceutical composition containing them, their use and intermediate product
|
JP8506194A
JPH10503508A
(en)
|
1994-07-29 |
1995-07-28 |
Benzoxazole and pyridine derivatives useful in the treatment of type II diabetes
|
PCT/EP1995/003038
WO1996004260A1
(en)
|
1994-07-29 |
1995-07-28 |
Benzoxazoles and pyridine derivatives useful in the treatment of the type ii diabetes
|
CA002196079A
CA2196079A1
(en)
|
1994-07-29 |
1995-07-28 |
Benzoxazoles and pyridine derivatives useful in the treatment of the type ii diabetes
|
HU9700264A
HUT76637A
(en)
|
1994-07-29 |
1995-07-28 |
Bezoxazoles and pyridine derivatives, pharmaceutical compositions containing them, process for producing them and their use and the intermediates of the compounds
|
NZ292125A
NZ292125A
(en)
|
1994-07-29 |
1995-07-28 |
Benzoxazole and pyridine substituted phenyl carboxylic acid derivatives; medicaments
|
APAP/P/1997/000918A
AP776A
(en)
|
1994-07-29 |
1995-07-28 |
Benzoxazoles and pyridine derivatives useful in the treatment of the type Ii diabetes.
|
FI970357A
FI970357A
(en)
|
1994-07-29 |
1997-01-28 |
Benzoxazole and pyridine derivatives useful in the treatment of type II diabetes
|
NO970373A
NO307827B1
(en)
|
1994-07-29 |
1997-01-28 |
Benzoxazole and pyridine derivatives, their use and pharmaceutical preparations containing them
|
OA60957A
OA10470A
(en)
|
1994-07-29 |
1997-01-29 |
Benzoxazoles and pyridine derivates useful in the treatment of the type ii diabetes
|
BG101180A
BG101180A
(en)
|
1994-07-29 |
1997-01-29 |
Benzoxazoles and pyridine derivatives useful in the treatment of the type ii diabetes
|
IL12552598A
IL125525A0
(en)
|
1994-07-29 |
1998-07-27 |
Hydroxyalkylamine derivatives
|
AU10061/99A
AU1006199A
(en)
|
1994-07-29 |
1999-01-08 |
Benzoxazoles and pyridine derivatives useful in the treatment of the Type II diabetes
|